Maarten van Wijhe1, Scott A McDonald2, Hester E de Melker2, Maarten J Postma3, Jacco Wallinga4. 1. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Unit of PharmacoEpidemiology & PharmacoEconomics (PE(2)), Department of Pharmacy, University of Groningen, Groningen, Netherlands. Electronic address: maarten.van.wijhe@rivm.nl. 2. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands. 3. Unit of PharmacoEpidemiology & PharmacoEconomics (PE(2)), Department of Pharmacy, University of Groningen, Groningen, Netherlands; Institute of Science in Healthy Aging & health caRE (SHARE), University Medical Center Groningen, Groningen, Netherlands. 4. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands.
Abstract
BACKGROUND: In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. METHODS: We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. FINDINGS: In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000). INTERPRETATION: Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. FUNDING: Dutch Ministry of Health, Welfare and Sport.
BACKGROUND: In the 20th century, childhood mortality decreased rapidly, and vaccination programmes are frequently suggested as a contributing factor. However, quantification of this contribution is subject to debate or absent. We present historical data from the Netherlands that allow us to quantify the reduction in childhood mortality burden for vaccine-preventable diseases in this period as a function of vaccination coverage. METHODS: We retrieved cause-specific and age-specific historical mortality data from Statistics Netherlands from 1903 to 2012 (for Dutch birth cohorts born from 1903 to 1992), and data for vaccination coverage since the start of vaccination programmes from the Dutch Health Care Inspectorate and the Dutch National Institute for Public Health and the Environment. We also obtained birth and migration data from Statistics Netherlands. We used a restricted mean life-time method to estimate cause-specific mortality burden among children and young adults for each birth cohort as the years of life lost up to age 20 years, excluding migration as a variable because this did not affect the results. To correct for long-term trends, we calculated the cause-specific contribution to the total childhood mortality burden. FINDINGS: In the prevaccination era, the contribution to mortality burden was fairly constant for diphtheria (1·4%), pertussis (3·8%), and tetanus (0·1%). Around the start of mass vaccinations, these contributions to the mortality burden decreased rapidly to near zero. We noted similar patterns for poliomyelitis, mumps, and rubella. The number of deaths due to measles around the start of vaccination in the Netherlands were too few to detect an accelerated rate of decrease after mass vaccinations were started. We estimate that mass vaccination programmes averted 148 000 years of life lost up to age 20 years (95% prediction interval 110 000-201 000) among children born before 1992. This corresponds to about 9000 deaths averted (6000-12 000). INTERPRETATION: Our historical time series analysis of mortality and vaccination coverage shows a strong association between increasing vaccination coverage and diminishing contribution of vaccine-preventable diseases to overall mortality. This analysis provides further evidence that mass vaccination programmes contributed to lowering childhood mortality burden. FUNDING: Dutch Ministry of Health, Welfare and Sport.
Authors: M van Wijhe; A D Tulen; H Korthals Altes; S A McDonald; H E de Melker; M J Postma; J Wallinga Journal: Epidemiol Infect Date: 2018-03-14 Impact factor: 4.434
Authors: Jeanne Heil; Henriëtte L G Ter Waarbeek; Christian J P A Hoebe; Peter H A Jacobs; Dirk W van Dam; Thera A M Trienekens; Jochen W L Cals; Inge H M van Loo; Nicole H T M Dukers-Muijrers Journal: Euro Surveill Date: 2017-07-13
Authors: Oscar Mesalles-Naranjo; Ian Grant; Grant M A Wyper; Diane Stockton; Richard Dobbie; Mag McFadden; Elaine Tod; Neil Craig; Colin M Fischbacher; Gerry McCartney Journal: PLoS One Date: 2018-08-01 Impact factor: 3.240
Authors: Susanne M A J Tielemans; Hester E de Melker; Susan J M Hahné; Anna G C Boef; Fiona R M van der Klis; Elisabeth A M Sanders; Marianne A B van der Sande; Mirjam J Knol Journal: BMJ Date: 2017-08-30
Authors: Angel Paternina-Caicedo; Julia Driessen; Mark Roberts; Willem Gijsbert van Panhuis Journal: Open Forum Infect Dis Date: 2018-06-16 Impact factor: 3.835